Analysts think IOBT stock price could increase by 837%
Dec 28, 2024, 12:26 PM
-3.57%
What does IOBT do
IO Biotech develops immune-modulating cancer therapies using its Twin technology platform, targeting tumor-induced immunosuppression. Its lead candidate, IO102-IO103, addresses key proteins IDO and PD-L1.
6 analysts think IOBT stock price will increase by 836.73%. The current median analyst target is $9.18 compared to a current stock price of $0.98. The lowest analysts target is $6.06 and the highest analyst target is $12.60.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.